Scientists develop a modified genetic transformation platform to study apomixis candidate genes in bahiagrass, potentially revolutionizing agriculture.
Discover how targeting neddylation with MLN4924 could overcome cisplatin resistance in ovarian cancer, offering new hope for patients with recurrent disease.
New research reveals how Zoledronic acid dismantles EMT's machinery by targeting NEDD9, silencing prostate cancer's invasive voice.
Explore how systems biology is transforming Parkinson's disease research through network analysis, multi-omics integration, and novel therapeutic approaches.
Explore how PROTACs are revolutionizing medicine by targeting previously 'undruggable' proteins for degradation, with clinical breakthroughs in cancer and neurodegenerative diseases.
Discover how SENP5 promotes esophageal squamous cell carcinoma growth through the NF-κB-SLC1A3 axis and its potential as a therapeutic target.
Exploring the genetic differences between glioblastoma's contrast-enhancing tumor core and infiltrative periphery that drive treatment resistance.
A comprehensive bibliometric analysis of mitochondrial research in Parkinson's disease, exploring growth trends, key discoveries, and future directions.
Exploring the roles of HLTF and SHPRH proteins in DNA damage repair and their implications in cancer prevention and treatment.
Exploring the critical role of USP47 in cancer metastasis through epithelial-mesenchymal transition (EMT) and its potential as a therapeutic target.